Current Opinion in Allergy and Clinical Immunology · 2001 · 96 citations · 68 references
MedicineToxicologyInflammationPediatric PulmonologyPulmonologyChronic Obstructive Pulmonary DiseaseInflammatory BiomarkersObstructive Lung DiseaseRespiratory MonitoringRespiratory PathophysiologyVolatile Organic CompoundsExhaled Air SamplingExhaled Breath Condensate AnalysisExhaled Nitric OxideLung DiseasesLung Inflammation BiomarkersNitric OxideNoninvasive SensingVolatile Organic Compound Biomarkers
Exhaled markers of inflammation allow completely noninvasive monitoring of inflammation and oxidative stress in the respiratory tract in inflammatory lung diseases, including asthma, chronic obstructive pulmonary disease, cystic fibrosis, bronchiectasis and interstitial lung diseases. Such noninvasive techniques are simple to perform, may be repeated frequently and can be applied in children, including neonates and patients with severe disease in whom more invasive procedures are not possible. Several volatile chemicals can be measured in the breath (nitric oxide, carbon monoxide, hydrocarbons), and many nonvolatile molecules (mediators, oxidation and nitration products, proteins) may be measured in exhaled breath condensate.
68
Increased nitric oxide in exhaled air of asthmatic patients
Sergei A. Kharitonov, D. H. Yates, R A Robbins et al. · The Lancet · 1994 · 1.4K citations
Medicine, Internal Medicine, Allergy +14
Paolo Montuschi, John V. Collins, Giovanni Ciabattoni et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 547 citations